Inhibitory effect of cetirizine on cytokine-enhanced in vitro eosinophil survival

Annals of Allergy, Asthma and Immunology

Volumn 78, Issue 6, 1997, Pages 581-585

  Sedgwick, Julie B ^a,b   Busse, William W ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b CSC H6/367   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHISTAMINIC AGENT; CETIRIZINE; CYTOKINE; DEXAMETHASONE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 3; INTERLEUKIN 5; MONOCLONAL ANTIBODY;

ADULT; ALLERGIC RHINITIS; ARTICLE; CELL CULTURE; CELL ISOLATION; CELL SURVIVAL; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; EOSINOPHIL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; SKIN TEST;

EID: 0030963224     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)63219-X     Document Type: Article

References (33)

1. Bousquet J, Chanez P, Lacoste JY, et al. Eosinophilic inflammation in asthma. N Engl J Med 1990;323: 1033-9.
2. Kroegel C, Virchow JC, Luttmann W, et al. Pulmonary immune cells in health and disease: the eosinophil leucocyte. Part 1. Eur Respir J 1994;7: 519-43.
3. Gleich GJ. The eosinophil and bronchial asthma: current understanding. J Allergy Clin Immunol 1990;85: 422-36.
4. Venge P. Eosinophil-derived inflammatory mediators; in Jolles G, Karlsson J-A, Taylor J, eds. T-lymphocyte and inflammatory cell research in asthma. New York: Academic Press, 1993;133-49.
5. Sedgwick JB, Calhoun WJ, Vrtis RF, et al. Comparison of airway and blood eosinophil function after in vivo antigen challenge. J Immunol 1992;149: 3710-8.
6. Ohnishi T, Kita H, Weiler D, et al. IL-5 is the predominant eosinophilactive cytokine in the antigen-induced pulmonary late phase reaction. Am Rev Respir Dis 1993;147:901-7.
7. Owen WF, Rothenberg ME, Silberstein DS, et al. Regulation of human eosinophil viability, density, and function by granulocyte/macrophage colony-stimulating factor in the presence of 3T3 fibroblasts. J Exp Med 1987; 166:129-41.
8. Rothenberg ME, Owen WF, Jr, Silberstein DS, et al. Human eosinophils have prolonged survival, enhanced functional properties, and become hypodense when exposed to human interleukin 3. J Clin Invest 1988;81: 1986-92.
9. Rothenberg ME, Petersen J, Stevens RL, et al. IL-5-dependent conversion of normodense human eosinophils to the hypodense phenotype uses 3T3 fibroblasts for enhanced viability, accelerated hypodensity, and sustained antibody-dependent cytotoxicity. J Immunol 1989;143:2311-6.
10. Weller PF. Cytokine regulation of eosinophil function. Clin Immunol Immunopathol 1992;62:S55-S59.
11. Altman LC, Hill JS, Hairfield WM, Mullarkey MF. Effects of corticosteroids on eosinophil chemotaxis and adherence. J Clin Invest 1981;67:28-36.
12. Her E, Frazer J, Austen KF, Owen WF, Jr. Eosinophil hematopoietins antagonize the programmed cell death of eosinophils. Cytokine and glucocorticoid effects on eosinophils maintained by endothelial cell-conditioned medium. J Clin Invest 1991;88:1982-7.
13. Lamas AM, Marcotte GV, Schleimer RP. Human endothelial cells prolong eosinophil survival. Regulation by cytokines and glucocorticoids. J Immunol 1989;142:3978-84.
14. Townley RG. Antiallergic properties of the second-generation H1 antihistamines during the early and late reactions to antigen. J Allergy Clin Immunol 1992;90:720-5.
15. Townley RG, Okada C. Use of cetirizine to investigate non-H1 effects of second-generation antihistamines. Ann Allergy 1992;68:190-6.
16. Rédier H, Chanez P, DeVos C, et al. Inhibitory effect of cetirizine on the bronchial eosinophil recruitment induced by allergen inhalation challenge in allergic patients with asthma. J Allergy Clin Immunol 1992;90:215-24.
17. Rihoux JP. The inhibiting effect of cetirizine 2 HC1 on eosinophil migration and its link to H1 blockade. Agent Act 1991;33(Suppl):409-14.
18. Rafferty P. Antihistamines in the treatment of clinical asthma. J Allergy Clin Immunol 1990;86:647-50.
19. Fadel R, David B, Herpin-Richard N, et al. In vivo effects of cetirizine on cutaneous reactivity and eosinophil migration induced by platelet-activating factor (PAF-acether) in man. J Allergy Clin Immunol 1990;86:314-20.
20. 1 antihistamines. J Am Acad Dermatol 1991;24:1094-6.
21. Kyan-Aung U, Hallsworth M, Haskard D, et al. The effects of cetirizine on the adhesion of human eosinophils and neutrophils to cultured human umbilical vein endothelial cells. J Allergy Clin Immunol 1992;90:270-2.
22. De Vos C, Joseph M, Leprovost C, et al. Inhibition of human eosinophil chemotaxis and of the IgE-dependent stimulation of human blood platelets by cetirizine. Int Arch Allergy Appl Immunol 1989;88:212-5.
23. Frick WE, Sedgwick JB, Busse WW. The appearance of hypodense eosinophils in antigen-dependent late phase asthma. Am Rev Respir Dis 1989;139: 1401-6.
24. Robinson DS, Ying S, Bentley AM, et al. Relationships among numbers of bronchoalveolar lavage cells expressing messenger ribonucleic acid for cytokines, asthma symptoms, and airway methacholine responsiveness in atopic asthma. J Allergy Clin Immunol 1993; 92:397-403.
25. Virchow JC, Walker C, Hafner D, et al. T cells and cytokines in bronchoalveolar lavage fluid after segmentai allergen provocation in atopic asthma. Am J Respir Crit Care Med 1995;151: 960-8.
26. Martins MA, Pasquale CP, Silva PM, et al. Interference of cetirizine with the late eosinophil accumulation induced by either PAF or compound 48/80. Br J Pharmacol 1992;105:176-80.
27. Okada C, Eda R, Miyagawa H, et al. Effect of cetirizine on human eosinophil superoxide generation, eosinophil chemotaxis and eosinophil peroxidase in vitro. Int Arch Allergy Immunol 1994;103:384-90.
28. Kantar A, Rihoux J, Fiorini R. Effect of cetirizine on plasma membrane of human eosinophils, neutrophils and platelets- a dose response study. Eur J Pharma Sci 1996;4:101-7.
29. 1-receptor antagonists on the activation of human basophils. Agents Actions 1994;41:C45-C46.
30. Walsh GM, Moqbel R, Hartnell A, Kay AB. Effects of cetirizine on human eosinophil and neutrophil activation in vitro. Int Arch Allergy Appl Immunol 1991;95:158-62.
31. Moncrieff J. Determination of cetirizine in serum using reversed-phase high performance liquid chromatography with ultraviolet spectrophotometric detection. J Chromatog 1992;583: 128-30.
32. Condino-Neto A, Muscara MN, Bozza PT, et al. The effect of a 1-week administration of cetirizine on the chemotaxis and superoxide anion production of neutrophils from healthy volunteers. Int J Clin Pharmacol Thera 1996;34:96-100.
33. Davies FJ, Bagnall AC, McCabe RN, et al. Antihistamines: topical vs oral administration. Clin Exp Allergy 1996; 26:11-7.